Issue 4/2011

Clinical relevance of thiopurine S-methyltransferase gene polymorphisms (277 — 282)

B. MLADOSIEVICOVA, A. DZURENKOVA, S. SUFLIARSKA, A. CARTER

DOI: 10.4149/neo_2011_04_277

Do we know the cause of the highest colorectal cancer incidence, the changes in the mortality trends and the clinical stages in the Slovak and Czech Republic, the representatives of the Central European region? (283 — 290)

M. ONDRUSOVA, J. MUZIK, R. HRCKA, L. FRIEDOVA, D. ONDRUS

DOI: 10.4149/neo_2011_04_283

Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin’s lymphoma using 18F-FDG-PET/CT (291 — 297)

T. PAPAJIK, M. MYSLIVECEK, M. SKOPALOVA, A. MALAN, E. BURIANKOVA, V. KOZA, M. HNATKOVA, M. TRNENY, Z. SEDOVA, Z. KUBOVA, P. KORANDA, P. FLODR, J. JARKOVSKY, L. DUSEK, K. INDRAK

DOI: 10.4149/neo_2011_04_291

Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients (298 — 303)

T. JAMASPISHVILI, A. SCORILAS, M. KRAL, I. KHOMERIKI, D. KURFURSTOVA, Z. KOLAR, J. BOUCHAL

DOI: 10.4149/neo_2011_04_298

GST isoenzymes in matched normal and neoplastic breast tissue (304 — 310)

S. OGUZTUZUN, A. ABU-HIJLEH, T. COBAN, D. BULBUL, M. KILIC, M. ISCAN, M. ISCAN

DOI: 10.4149/neo_2011_04_304

Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer (311 — 319)

M. KOZLOWSKI, W. NAUMNIK, J. NIKLINSKI, R. MILEWSKI, P. DZIEGIELEWSKI, J. LAUDANSKI

DOI: 10.4149/neo_2011_04_311

Effect of justicidin B – a potent cytotoxic and pro-apoptotic arylnaphtalene lignan on human breast cancer-derived cell lines (320 — 325)

G. MOMEKOV, S. KONSTANTINOV, I. DINEVA, I. IONKOVA

DOI: 10.4149/neo_2011_04_320

Blood stream infections throught the entire course of acute lymphoblastic leukemia treatment (326 — 330)

K. KATSIBARDI, V. PAPADAKIS, A. CHARISIADOU, A. PANGALIS, S. POLYCHRONOPOULOU

DOI: 10.4149/neo_2011_04_326

Lymphatic vessel density and expressions of lymphangiogenic growth factors in salivary carcinomas (331 — 336)

M. F. MELLO, A. F. COSTA, L. L. FREITAS, A. B. SOARES, V. C. ARAUJO, A. J. TINCANI, A. S. MARTINS, A. ALTEMANI

DOI: 10.4149/neo_2011_04_331

Impact of blood processing on estimation of soluble HLA-G (337 — 342)

K. POLÁKOVÁ, E. BANDŽUCHOVÁ, G. RUSS

DOI: 10.4149/neo_2011_04_337

Gamma-secretase inhibitor, a potential target therapy for MUC2-positive colorectal carcinoma (343 — 347)

X. BU, N. LI, X. TIAN, P. HUANG

DOI: 10.4149/neo_2011_04_343

Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients (348 — 351)

S. OZKAYA, S. FINDIK, A. G. ATICI, A. DIRICA

DOI: 10.4149/neo_2011_04_348

Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: A meta-analysis (352 — 359)

D. WANG, B. WANG, J. X. ZHAI, D. W. LIU, G. G. SUN

DOI: 10.4149/neo_2011_04_352